K. Ouchi et al., HISTOLOGIC FEATURES AND CLINICAL-SIGNIFICANCE OF VENOUS INVASION IN COLORECTAL-CARCINOMA WITH HEPATIC METASTASIS, Cancer, 78(11), 1996, pp. 2313-2317
BACKGROUND. In colorectal carcinoma, venous invasion has been related
to patient survival. Liver metastasis develops more frequently when ve
nous invasion is present. However, the histologic features and clinica
l significance of venous invasion are not well understood. METHODS. A
histologic study of venous invasion in colorectal carcinoma was perfor
med on 19 patients with synchronous hepatic metastasis (Group A), 16 p
atients with metachronous hepatic metastasis (Group B), and 26 patient
s with Dukes Stage C tumors who survived for 5 years without recurrenc
e (Group C). The histologic features of venous invasion were classifie
d into three types: tumor cells that were distant from the vein walls
were categorized as floating type, those filling the lumen of a vein a
s filling type, and those surrounded by a vein obliterated with inflam
matory reaction as occlusive type. RESULTS. Venous invasion was presen
t in 89.5% of Group A patients and 75% of Group B patients, which was
significantly higher than the 15.4% observed in Group C patients (P <
0.001). A slight to extensive degree of venous invasion was found in G
roups A and B, but no extensive venous invasion was found in Group C.
All patients in Groups A and B (except one patient) had floating, fill
ing, or a combination of floating and filling types of venous invasion
, whereas all patients in Group C had the occlusive type of venous inv
asion. A majority of the patients in all three groups showed invasion
of extramural veins. CONCLUSIONS. There is a close relationship betwee
n venous invasion and the development of liver metastasis in patients
With colorectal carcinoma. Patients With no sign of metastasis had a l
ower incidence and lower extent of venous invasion, and inflammatory d
amage to the vein walls around the intravenous tumor appeared to reduc
e the likelihood of distant metastasis. (C) 1996 American Cancer Socie
ty.